News | January 12, 2023
Genome sequencing solutions will help to bring precision in lung cancer therapy, says GlobalData
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Subscribe To Our Newsletter & Stay Updated
